Stability of the 13C column separation in industrial mode of operation
Based on the original cryogenic column conceived and built by National Institute for Research and Development of Isotopic and Molecular Technologies Cluj-Napoca, it is necessary to implement control algorithms for the industrial mode of operation of this equipment, in order to produce some chemical compounds with higher concentration in (13C), compounds asked in various domains. The present work deals with column efficiency analysis and stability in industrial mode of operation.
Level and pressure control in condenser of the 13C isotope separation column
The process of the 13C in cryogenic separation column is an intricate one. A lot of parameters must be kept constant at empirical values. From among these, the nitrogen level and the temperature in condenser are essential for the separation process. In present, the liquid nitrogen level is controlled manually and any error of the operators can waste the final product. The paper proposes not only a system for liquid nitrogen level control, but also a second system able to decrease — due to the under-pressure — the evaporation temperature of liquid nitrogen in order to improve the separation process. The paper analyzes the two systems as independent entities and the interinfluences are treated as disturbances. The analysis in the true MIMO frame is a future task.
Electrophysiological Studies of Penticainide (CM 7857), a New Antiarrhythmic Agent, in Mammalian Myocardium
The intracellular electrophysiologic properties of a new antiarrhythmic substance, penticainide, were studied in isolated rabbit, dog, and guinea pig myocardial preparations superfused or perfused with oxygenated Tyrode's solution. “Therapeutic” concentrations of penticainide (1.5 to 3 x 10-5 M) had little effect on sinus node automaticity; sinoatrial conduction was slightly delayed. In atrial, Purkinje and ventricular fibers, amplitude, and maximal rate of rise of phase 0 (dV/dtmax) were decreased by penticainide; Purkinje-ventricle conduction velocity was depressed. Penticainide did not significantly modify action potential duration (APD) of rabbit atria and dog ventricle and reduced APD and effective refractory period (ERP) of dog Purkinje and guinea pig ventricular fibers. Penticainide reduced APD heterogeneity of Purkinje-ventricle junction with a preferential effect at the gate and decreased tension amplitude of perfused papillary muscle in dog heart. The effect of penticainide on dV/dtmax was voltage and rate dependent; the resting block was weak. Thus, penticainide is a class 1 antiarrhythmic agent with properties of class 1B agents such as APD reduction and properties of class 1C agents such as slow recovery kinetic of rate-dependent block.